MCID: THY030
MIFTS: 51

Thyroid Gland Disease

Categories: Endocrine diseases

Aliases & Classifications for Thyroid Gland Disease

MalaCards integrated aliases for Thyroid Gland Disease:

Name: Thyroid Gland Disease 12 15
Abnormality of the Thyroid Gland 30 6
Thyroid Diseases 45 74

Classifications:



External Ids:

Disease Ontology 12 DOID:50
MeSH 45 D013959
NCIt 51 C26893
SNOMED-CT 69 14304000
ICD10 34 E00-E07 E07.9
UMLS 74 C0040128

Summaries for Thyroid Gland Disease

Disease Ontology : 12 An endocrine system disease that is located in the thyroid.

MalaCards based summary : Thyroid Gland Disease, also known as abnormality of the thyroid gland, is related to hyperthyroxinemia and hyperthyroidism. An important gene associated with Thyroid Gland Disease is TG (Thyroglobulin), and among its related pathways/superpathways are Aldosterone synthesis and secretion and G alpha (s) signalling events. The drugs Iodine and Dexmedetomidine have been mentioned in the context of this disorder. Affiliated tissues include thyroid, eye and testes, and related phenotypes are no effect and endocrine/exocrine gland

Related Diseases for Thyroid Gland Disease

Diseases related to Thyroid Gland Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 299)
# Related Disease Score Top Affiliating Genes
1 hyperthyroxinemia 32.3 SERPINA7 TPO TRH TSHR
2 hyperthyroidism 31.9 SERPINA7 TG THRB TPO TRH TSHR
3 graves disease 1 31.6 DIO2 SERPINA7 TG THRB TPO TRH
4 goiter 31.0 CALCA NKX2-1 PAX8 SERPINA7 SLC26A4 SLC5A5
5 thyroid cancer 30.8 CALCA DIO2 FOXE1 NCOA4 NKX2-1 PAX8
6 graves' disease 30.6 DIO2 SERPINA7 TG TPO TSHR
7 hypothyroidism 30.6 CALCA DIO2 FOXE1 NKX2-1 PAX8 RET
8 myxedema 30.6 TG TPO TSHR
9 thyroid carcinoma, familial medullary 30.5 CALCA NKX2-1 RET TG
10 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 30.5 TG TPO TSHR
11 thyroiditis 30.2 CALCA RET SERPINA7 TG THRB TPO
12 neonatal hypothyroidism 30.2 PAX8 SLC5A5 TG TPO TSHR
13 nodular goiter 30.2 CALCA RET SLC5A5 TG TPO TSHR
14 primary hyperparathyroidism 30.2 CALCA PTH RET
15 hyperparathyroidism 30.2 CALCA PTH RET
16 subacute thyroiditis 30.1 SERPINA7 TG TPO TSHR
17 hashimoto thyroiditis 30.1 CALCA RET SLC26A4 TG TPO TSHB
18 familial thyroid dyshormonogenesis 30.0 SLC5A5 TG TPO
19 parathyroid adenoma 29.9 CALCA PTH RET
20 endemic goiter 29.8 PTH SERPINA7 TG TPO TSHB TSHR
21 multinodular goiter 29.8 CALCA NKX2-1 PAX8 SLC26A4 TG TPO
22 papillary carcinoma 29.8 CALCA NCOA4 NKX2-1 PAX8 RET TG
23 pendred syndrome 29.8 PAX8 SLC26A4 TG TPO
24 hypothyroidism, congenital, nongoitrous, 4 29.7 SERPINA7 TG TPO TRH TSHB
25 differentiated thyroid carcinoma 29.5 FOXE1 NCOA4 NKX2-1 PAX8 RET TG
26 follicular adenoma 29.3 CALCA NKX2-1 PAX8 RET SLC26A4 TG
27 congenital hypothyroidism 29.3 FOXE1 NKX2-1 PAX8 SERPINA7 SLC26A4 SLC5A5
28 autoimmune thyroid disease 3 12.3
29 igg4-related thyroid disease 12.1
30 autoimmune thyroid disease 1 12.1
31 autoimmune thyroid disease 2 12.1
32 autoimmune thyroid disease 4 12.1
33 autoimmune polyendocrine syndrome, type ii 11.7
34 vitiligo-associated multiple autoimmune disease susceptibility 1 11.2
35 carpal tunnel syndrome 11.1
36 candidiasis, familial, 1 11.0
37 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 10.8
38 cholangitis, primary sclerosing 10.8
39 mthfr gene variant 10.8
40 clear cell adenoma 10.5 PTH TG
41 mucoepidermoid thyroid carcinoma 10.5 CALCA TG
42 subacute lymphocytic thyroiditis 10.5 TG TPO
43 hashimoto encephalopathy 10.5 TPO TSHR
44 suppurative thyroiditis 10.5 CALCA TG
45 thyroid sarcoma 10.5 CALCA TG
46 ovarian germ cell teratoma 10.5 NKX2-1 RET TG
47 goiter, multinodular 1, with or without sertoli-leydig cell tumors 10.5 TG TPO
48 substernal goiter 10.5 PTH TG
49 postsurgical hypothyroidism 10.5 TG TRH TSHR
50 plummer's disease 10.5 TG THRB TPO

Comorbidity relations with Thyroid Gland Disease via Phenotypic Disease Network (PDN):


Hypertension, Essential Hypothyroidism

Graphical network of the top 20 diseases related to Thyroid Gland Disease:



Diseases related to Thyroid Gland Disease

Symptoms & Phenotypes for Thyroid Gland Disease

GenomeRNAi Phenotypes related to Thyroid Gland Disease according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 no effect GR00402-S-1 9.92 CALCA DIO2 FOXE1 NCOA4 NKX2-1 PAX8

MGI Mouse Phenotypes related to Thyroid Gland Disease:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 10.18 DIO2 FOXE1 NKX2-1 PAX8 PTH RET
2 homeostasis/metabolism MP:0005376 10.16 DIO2 FOXE1 NCOA4 NKX2-1 PAX8 PTH
3 cellular MP:0005384 10.13 NCOA4 NKX2-1 PAX8 PTH RET SLC5A5
4 growth/size/body region MP:0005378 10.1 DIO2 FOXE1 NKX2-1 PAX8 PTH RET
5 digestive/alimentary MP:0005381 9.95 DIO2 FOXE1 NKX2-1 RET SLC26A4 TG
6 limbs/digits/tail MP:0005371 9.7 PAX8 PTH RET TG THRB TPO
7 no phenotypic analysis MP:0003012 9.5 NKX2-1 PAX8 RET THRB TPCN1 TRH
8 skeleton MP:0005390 9.28 DIO2 NKX2-1 PAX8 PTH SLC26A4 TG

Drugs & Therapeutics for Thyroid Gland Disease

Drugs for Thyroid Gland Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 881)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Iodine Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 7553-56-2 807
2
Dexmedetomidine Approved, Vet_approved Phase 4,Not Applicable 113775-47-6 68602 5311068
3
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
4
Diclofenac Approved, Vet_approved Phase 4,Phase 3 15307-86-5 3033
5
Selenium Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 7782-49-2
6
Methimazole Approved Phase 4,Phase 2,Phase 1,Not Applicable 60-56-0 1349907
7
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
8
Sevoflurane Approved, Vet_approved Phase 4,Not Applicable 28523-86-6 5206
9
Remifentanil Approved Phase 4,Not Applicable 132875-61-7 60815
10
Nitroprusside Approved, Investigational Phase 4 15078-28-1 11963622
11
Nitric Oxide Approved Phase 4,Not Applicable 10102-43-9 145068
12
Propylthiouracil Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 51-52-5 657298
13
Betamethasone Approved, Vet_approved Phase 4,Phase 3 378-44-9 9782
14
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754
15
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 53-03-2 5865
16
Hydrocortisone acetate Approved, Vet_approved Phase 4 50-03-3
17
Amiodarone Approved, Investigational Phase 4,Phase 3,Not Applicable 1951-25-3 2157
18
tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1401-55-4
19
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 94-09-7, 1994-09-7 2337
20
Somatostatin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 38916-34-6, 51110-01-1 53481605
21
Pasireotide Approved Phase 4,Phase 3,Phase 2 396091-73-9 9941444
22
Octreotide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 83150-76-9 6400441 383414
23
lanreotide Approved Phase 4,Phase 2 108736-35-2
24
Sodium Citrate Approved, Investigational Phase 4,Phase 2,Phase 1,Early Phase 1 68-04-2
25
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 302-25-0
26
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 50-24-8 5755
27
Methylprednisolone hemisuccinate Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 2921-57-5
28
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 83-43-2 6741
29
Triamcinolone Approved, Vet_approved Phase 4,Not Applicable 124-94-7 31307
30
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-28-2 5757
31
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 28014-46-2
32
Testosterone Approved, Experimental, Investigational Phase 4,Phase 1,Not Applicable,Early Phase 1 58-22-0, 481-30-1 6013 10204
33
Dinoprost Approved, Investigational Phase 4,Not Applicable 551-11-1 5283078
34
Dinoprost tromethamine Approved, Vet_approved Phase 4,Not Applicable 38562-01-5 5282415
35
Propranolol Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 525-66-6 4946
36
Peginterferon alfa-2a Approved, Investigational Phase 4,Phase 2,Phase 3 198153-51-4 5360545
37
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
38
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1177-87-3
39
Hydroxocobalamin Approved Phase 4,Phase 2,Not Applicable 13422-51-0 11953898 15589840
40
Iron Approved, Experimental Phase 4,Phase 2,Phase 1,Not Applicable 7439-89-6, 15438-31-0 23925 27284
41
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 58-05-9 6006 143
42
Ribavirin Approved Phase 4,Phase 2,Phase 3 36791-04-5 37542
43
Peginterferon alfa-2b Approved Phase 4,Phase 2,Phase 3 99210-65-8, 215647-85-1
44
Sunitinib Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 557795-19-4, 341031-54-7 5329102
45
Glucagon Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 16941-32-5
46
Liraglutide Approved Phase 4,Phase 3,Phase 2,Not Applicable 204656-20-2 44147092
47
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Not Applicable 103-90-2 1983
48
Parathyroid hormone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 9002-64-6
49
Ethanol Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 64-17-5 702
50
Acetylcholine Approved, Investigational Phase 4,Phase 2,Phase 3 51-84-3 187

Interventional clinical trials:

(show top 50) (show all 1970)
# Name Status NCT ID Phase Drugs
1 rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors Unknown status NCT00902122 Phase 4 rAd-p53 gene;p53 gene therapy
2 Radiolabeled Molecules for Medullary Thyroid Cancer Unknown status NCT01915485 Phase 4
3 Thyroid Study Type 2 Diabetes Mellitus (T2DM) Unknown status NCT01379170 Phase 4 Euthyrox (levothyroxine)
4 Effects of Dexmedetomidine on Cough Response and Postoperative Recovery Quality in Patients Undergoing Thyroid Surgery With General Anesthesia Unknown status NCT02613806 Phase 4 Dexmeditomidine;normal saline
5 Etoricoxib for Postoperative Pain After Thyroid Surgery Unknown status NCT00935116 Phase 4 etoricoxib
6 Selenium Supplementation in Youths With Autoimmune Thyroiditis Unknown status NCT02644707 Phase 4
7 Cardiopulmonary Capacity in Elderly With Different Ranges of Serum Thyroid Stimulating Hormone Unknown status NCT01849861 Phase 4 Methimazole
8 Effect of Propofol on Remifentanil-induced Postoperative Hyperalgesia in Patients Undergoing Thyroid Surgery Unknown status NCT01189721 Phase 4 propofol, sevoflurane
9 Clinical Study Investigating the Effect of Sodium Nitroprusside Infusion on Thyroidal Function Unknown status NCT00636584 Phase 4 sodium nitroprusside;placebo
10 The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy Unknown status NCT01056419 Phase 4 Propylthiouracil
11 Total Thyroidectomy With Harmonic Scalpel® Unknown status NCT00385983 Phase 4
12 The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance Unknown status NCT02329379 Phase 4 Levothyroxine
13 Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism Unknown status NCT02316743 Phase 4 Levothyroxine supplementation
14 Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy Unknown status NCT02652884 Phase 4 phosphate and betamethasone acetate, 2 mL.;saline 0.9% NaCl
15 Trial Evaluating Use of Arista in Total Thyroidectomy Unknown status NCT02568085 Phase 4
16 Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions Unknown status NCT02190994 Phase 4 Hydrocortisone;Prednisone
17 Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission Unknown status NCT01901666 Phase 4 Growth Hormone
18 Thyroxine Titration Study Unknown status NCT00111735 Phase 4 Thyroxine
19 Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study Unknown status NCT01850277 Phase 4 Amiodarone;Pharmacotherapy to slow and control ventricular rate
20 Pasireotide LAR and Pegvisomant Study in Acromegaly Unknown status NCT02668172 Phase 4 Pasireotide LAR 60 mg;Pegvisomant
21 Sildenafil Activates Browning of White Adipose and Improves Insulin Sensitivity Unknown status NCT02524184 Phase 4 sildenafil;placebo
22 AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial Fibrillation Unknown status NCT02341105 Phase 4 Amiodarone
23 Clinical Trial to Evaluate the Efficacy of FITOGYN Versus Placebo on the Vasomotor Symptomatology Associated With Menopause Unknown status NCT01116310 Phase 4 Soy isoflavones (Glycine max L) and red clover extract (Trifolium pretense L);Placebo
24 Effect of Erythropoietin in Refractory Autoimmune Encephalitis Patients Unknown status NCT03004209 Phase 4 Erythropoietin
25 A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy Unknown status NCT01969019 Phase 4 methylprednisolone, prednisone
26 Effect of Higher Doses of Remifentanil on Postoperative Pain in Patients Undergoing Thyroidectomy Unknown status NCT01761149 Phase 4 Remifentanil
27 Percutaneous Laser Ablation in Benign Thyroid Nodules.Long Term Results Completed NCT00858104 Phase 4
28 Thyroid Hormone Replacement for Subclinical Hypothyroidism Completed NCT01660126 Phase 4 Levothyroxine;Placebo
29 Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer Completed NCT00604318 Phase 4 rhTSH
30 Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal. Completed NCT00001730 Phase 4 Thyrogen
31 Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism Completed NCT02500342 Phase 4 Levothyroxine;Placebo
32 Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction Completed NCT02491008 Phase 4 Levothyroxine;Placebo
33 Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections Completed NCT01599273 Phase 4 subconjunctival triamcinolone injection
34 A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women Completed NCT00224094 Phase 4 Premarin® (oral) vs. Alora® (transdermal)
35 The TRUST Trial - CardioVascular Imaging ECHO Completed NCT02832960 Phase 4 Levothyroxine;Placebo
36 The TRUST Study - CardioVascular Imaging IMT Completed NCT02832934 Phase 4 Levothyroxine;Placebo
37 Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) Completed NCT02059655 Phase 4 Bimatoprost;Eye drop solution
38 Thyroid Medication and Antidepressants for Treating Major Depression Completed NCT00208702 Phase 4 Triiodothyronine;Sertraline
39 Antithyroid Drugs During Radioiodine Therapy Completed NCT00150137 Phase 4 Methimazole
40 Block-replacement Therapy During Radioiodine Therapy Completed NCT00150124 Phase 4 MTZ+LT4;Methimazole
41 Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial Completed NCT00520338 Phase 4 celecoxib
42 The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus Completed NCT00463502 Phase 4 Metformin
43 Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit Completed NCT01921452 Phase 4
44 The TRUST Study - Depression Substudy Completed NCT01853579 Phase 4 Levothyroxine;Placebo
45 Is the Routine Pressure Dressing After Thyroidectomy Necessary? Completed NCT00400465 Phase 4
46 Effects of N-acetylcysteine on Low T3 Syndrome Completed NCT01501110 Phase 4 N-acetylcysteine
47 Dose-dependent Effect of Fentanyl on Cough Attenuation During Emergence From General Anaesthesia Completed NCT01308320 Phase 4 fentanyl citrate;saline
48 Neurocognitive and Metabolic Effects of Mild Hypothyroidism Completed NCT00565864 Phase 4 L-thyroxine (L-T4)
49 Effects of L-carnitine on Hypothyroidism Completed NCT01769157 Phase 4 L-carnitine;Placebo
50 Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism Completed NCT00206375 Phase 4 Growth hormone;Growth hormone treatment and puberty

Search NIH Clinical Center for Thyroid Gland Disease

Cochrane evidence based reviews: thyroid diseases

Genetic Tests for Thyroid Gland Disease

Genetic tests related to Thyroid Gland Disease:

# Genetic test Affiliating Genes
1 Abnormality of the Thyroid Gland 30

Anatomical Context for Thyroid Gland Disease

MalaCards organs/tissues related to Thyroid Gland Disease:

42
Thyroid, Eye, Testes, Lymph Node, Brain, Bone, Prostate

The Foundational Model of Anatomy Ontology organs/tissues related to Thyroid Gland Disease:

20
The Thyroid

Publications for Thyroid Gland Disease

Articles related to Thyroid Gland Disease:

# Title Authors Year
1
Multi-immunoreaction-based dual-color capillary electrophoresis for enhanced diagnostic reliability of thyroid gland disease. ( 28645753 )
2017
2
Cost-of-Illness Trend of Thyroid Gland Disease in Korea. ( 25309782 )
2014
3
Modern concepts of preoperative preparation of patients with thyroid gland disease. ( 21879658 )
2011
4
Localized crossed hyperhidrosis and the coexistence of thyroid gland disease. ( 20536672 )
2010
5
Application of thermography for non-invasive diagnosis of thyroid gland disease. ( 18334410 )
2008
6
Methodology of the thyroid gland disease decision-making using profiling in steroid hormone pathway. ( 17081718 )
2007
7
[Classification of thyroid gland disease on the basis of selenium concentration in serum]. ( 18246662 )
2007
8
Indications for surgery in thyroid gland disease. ( 13612484 )
1958

Variations for Thyroid Gland Disease

ClinVar genetic disease variations for Thyroid Gland Disease:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 COL7A1 NM_000094.3(COL7A1): c.1442G> A (p.Arg481His) single nucleotide variant Likely pathogenic rs147040026 GRCh38 Chromosome 3, 48591738: 48591738
2 COL7A1 NM_000094.3(COL7A1): c.1442G> A (p.Arg481His) single nucleotide variant Likely pathogenic rs147040026 GRCh37 Chromosome 3, 48629171: 48629171

Expression for Thyroid Gland Disease

Search GEO for disease gene expression data for Thyroid Gland Disease.

Pathways for Thyroid Gland Disease

GO Terms for Thyroid Gland Disease

Cellular components related to Thyroid Gland Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell GO:0005623 8.8 DIO2 PTH TXNRD2

Biological processes related to Thyroid Gland Disease according to GeneCards Suite gene sharing:

(show all 14)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription, DNA-templated GO:0045893 9.91 FOXE1 NCOA4 NKX2-1 PAX8 RET
2 regulation of signaling receptor activity GO:0010469 9.85 CALCA PTH TG TRH TSHB
3 cell-cell signaling GO:0007267 9.77 CALCA PTH TRH TSHB TSHR
4 anatomical structure morphogenesis GO:0009653 9.7 FOXE1 PAX8 TSHB
5 adenylate cyclase-activating G protein-coupled receptor signaling pathway GO:0007189 9.67 CALCA PTH TSHR
6 hormone-mediated signaling pathway GO:0009755 9.56 THRB TRH TSHB TSHR
7 response to pain GO:0048265 9.54 CALCA RET
8 hormone biosynthetic process GO:0042446 9.5 DIO2 TG TPO
9 thyroid hormone metabolic process GO:0042403 9.48 DIO2 TG
10 cellular response to gonadotropin stimulus GO:0071371 9.43 PAX8 SLC5A5
11 thyroid-stimulating hormone signaling pathway GO:0038194 9.4 PAX8 TSHR
12 iodide transport GO:0015705 9.33 SLC26A4 SLC5A5 TG
13 thyroid hormone generation GO:0006590 9.26 DIO2 FOXE1 SLC5A5 TPO
14 thyroid gland development GO:0030878 9.02 FOXE1 NKX2-1 PAX8 TG THRB

Molecular functions related to Thyroid Gland Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 iodide transmembrane transporter activity GO:0015111 9.16 SLC26A4 SLC5A5
2 hormone activity GO:0005179 9.02 CALCA PTH TG TRH TSHB
3 thyroid-stimulating hormone receptor activity GO:0004996 8.96 PAX8 TSHR

Sources for Thyroid Gland Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....